Kardigan
Diane Hagerty is a seasoned professional in the field of quality and compliance within the pharmaceutical and biotechnology sectors. Currently serving as the Chief Quality Officer at Kardigan, Diane has a diverse background as a self-employed Pharma/Biotech Quality Executive. Previously, Diane held the position of Senior Vice President and Head of GxP Quality & Compliance at Allogene Therapeutics and served as Vice President for the same area at MyoKardia, which was acquired by Bristol-Myers Squibb in November 2020. Additionally, Diane was the Senior Vice President of Quality, Compliance, and Operational Excellence at Dermira, Inc., prior to its acquisition by Eli Lilly in February 2020.
This person is not in any teams
This person is not in any offices
Kardigan
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve. For more information about Kardigan, please visit kardigan.bio. If you are interested in joining our passionate and driven team with deep cardiovascular, biotechnology and operational expertise, please visit kardigan.bio or the careers tab of this page.